Rox Anderson, MD In this presentation, Dr Anderson reviewed some of the emerging technologies in the field of dermatology. Topics discussed included: Microscopy Epidermal blister transfer blasting Restoring elastic recoil “Targeting” sebaceous glands “Optical tools are used quite often in diagnostics in the field of dermatology and the ability to get true microscopic cross-sectional imaging […]
Curtis Cole, PhD Dr Cole, VP of R&D at Johnson and Johnson Consumer Products reviewed some of the facts and myths about the use of sunscreen. Currently, there is lots of confusion about the use of sunscreen. Many believe that sunscreen use is doing more harm than good due to hormone disruption, “nano” materials, and […]
John Zone, MD Dr Zone, a leading expert in immunodermatology, presented some of the latest data on the management of bullous diseases. Therapies discussed included: Rituxumab (off label) -Pemphigus/mucus membrane pemphigoid IVIg (FDA approved)-Pemphigus/Pemphigoid IVIg (FDA approved)-Controversial for Toxic epidermal necrolysis (TEN)/Stevens-Johnson syndrome (SJS) IVIg (off label)-Scleromyxedema IgE and Omalizumab (off label) Rituximab has demonstrated […]
Our expert panel of pediatric dermatologists reviewed various topics in the field of pediatric dermatology including, hemangiomas, nail diseases, atopic dermatitis, inflammatory disorders, and skin lesions. Drs Friedlander and Frieden began the pediatric dermatology session with a discussion on infantile hemangiomas (IH). Dermatologists need to continue to understand the incidence and pathogenesis of IH and […]
Eggert Stockfleth, MD & George Martin, MD Viral Skin Carcinogenesis – Eggert Stockfleth, MD Dr Stockfleth reviewed the latest data and the role of the human papillomavirus (HPV) in skin cancer. SCC is prevalent on 80% of sun-exposed areas in cutaneous SCC and the main risk factor is UV radiation (UVA and UVB). There […]
Neil Swanson, MD & Marc Brown, MD Mohs Surgery: Thoughts and Guidelines – Neil Swanson, MD Dr Swanson begins by stating that Mohs surgery is NOT indicated for all BCC/SCC and this is an important concept for dermatologists. In 2012, a group of experts developed guidelines for the appropriate use of Mohs micrographic surgery published […]
Ted Rosen, MD & Neal Bhatia, MD Drs Ted Rosen and Neal Bhatia discussed new drugs and devices in 2013. Ted Rosen, MD Modified release prednisone (Rayos) is now on the market. Why would this be a reasonable therapeutic choice? For many inflammatory diseases, the cytokines peak overnight; yet, steroid administration is often done in the […]
This session began with a series of interactive case challenges and discussions on the optimal management congenital melanocytic nevi. Our panelists included Drs Hensin Tsao, Ashfaq Marghoob, Keith Flaherty, Whitney High, Ilona Frieden and Ken Tanabe. Understanding the medical and surgical management of nevi and melanoma is extremely important for the practicing dermatologist. Nevi are […]
Hensin Tsao, MD, PhD Dr Hensin Tsao, Director of the Melanoma Clinic at Massachusetts General Hospital, lead off the 2013 Maui Derm meeting by providing the audience with an overview of the top stories in dermatology in 2012-2013. New Observations Melanoma is the 5th most common cancer in males and the 6th most common cancer […]
Judy Seraphine, Medical Editor, Maui Derm News In this presentation, Dr Webster provides an update for the management of patients with rosacea. There have been a number of theories about rosacea. In the past, clinicians believed that it had to do with blushing but that was never clear. Since then, newer observations have been made […]
Administrative Office
Maui Derm
161 Wailea Ike Place, Suite A-104
Kihei, HI 96753
Stay Connected
Sign up to receive updates about upcoming meetings.